miniTUBA: medical inference by network integration of temporal data using Bayesian analysis

MOTIVATION Many biomedical and clinical research problems involve discovering causal relationships between observations gathered from temporal events. Dynamic Bayesian networks are a powerful modeling approach to describe causal or apparently causal relationships, and support complex medical inference, such as future response prediction, automated learning, and rational decision making. Although many engines exist for creating Bayesian networks, most require a local installation and significant data manipulation to be practical for a general biologist or clinician. No software pipeline currently exists for interpretation and inference of dynamic Bayesian networks learned from biomedical and clinical data. RESULTS miniTUBA is a web-based modeling system that allows clinical and biomedical researchers to perform complex medical/clinical inference and prediction using dynamic Bayesian network analysis with temporal datasets. The software allows users to choose different analysis parameters (e.g. Markov lags and prior topology), and continuously update their data and refine their results. miniTUBA can make temporal predictions to suggest interventions based on an automated learning process pipeline using all data provided. Preliminary tests using synthetic data and laboratory research data indicate that miniTUBA accurately identifies regulatory network structures from temporal data. AVAILABILITY miniTUBA is available at http://www.minituba.org.

[1]  Kevin B. Korb,et al.  Bayesian Artificial Intelligence , 2004, Computer science and data analysis series.

[2]  N. Greenspan Conceptualizing immune responsiveness , 2007, Nature Immunology.

[3]  Christopher Kabrhel,et al.  Derivation and validation of a Bayesian network to predict pretest probability of venous thromboembolism. , 2004, Annals of emergency medicine.

[4]  G. Su,et al.  Altered Kupffer cell function in biliary obstruction. , 2005, Surgery.

[5]  OLAND,et al.  TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C , 2000 .

[6]  V. Haughton,et al.  Mapping functionally related regions of brain with functional connectivity MR imaging. , 2000, AJNR. American journal of neuroradiology.

[7]  Michael A. Malcolm,et al.  Computer methods for mathematical computations , 1977 .

[8]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.

[9]  G. Bernard,et al.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.

[10]  S. Opal,et al.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.

[11]  Min Zou,et al.  A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data , 2005, Bioinform..

[12]  William G. Baxt,et al.  Use of an Artificial Neural Network for Data Analysis in Clinical Decision-Making: The Diagnosis of Acute Coronary Occlusion , 1990, Neural Computation.

[13]  K. Hatakeyama,et al.  Impact of bactibilia on the development of postoperative abdominal septic complications in patients with malignant biliary obstruction. , 1999, International surgery.

[14]  Caroline Sabin,et al.  Medical Statistics at a Glance , 2000 .

[15]  Gérard Dreyfus,et al.  Neural networks - methodology and applications , 2005 .

[16]  D. Remick Cytokine therapeutics for the treatment of sepsis: why has nothing worked? , 2003, Current pharmaceutical design.

[17]  P. Mcclelland,et al.  Treatment of septic shock , 1991, The Lancet.

[18]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[19]  Rian,et al.  THE EFFECTS OF IBUPROFEN ON THE PHYSIOLOGY AND SURVIVAL OF PATIENTS WITH SEPSIS , 2000 .

[20]  M. Kendall,et al.  Kendall's advanced theory of statistics , 1995 .

[21]  G F Cooper,et al.  An evaluation of explanations of probabilistic inference. , 1992, Proceedings. Symposium on Computer Applications in Medical Care.

[22]  Xiaohui Liu,et al.  A spatio-temporal Bayesian network classifier for understanding visual field deterioration , 2005, Artif. Intell. Medicine.

[23]  Paul P. Wang,et al.  Advances to Bayesian network inference for generating causal networks from observational biological data , 2004, Bioinform..

[24]  Elizabeth S Burnside,et al.  Bayesian networks: computer-assisted diagnosis support in radiology. , 2005, Academic radiology.

[25]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[26]  J. W. Thomas Numerical Partial Differential Equations , 1999 .

[27]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[28]  K. Zou,et al.  Correlation and simple linear regression. , 2003, Radiology.

[29]  S Van Huffel,et al.  Predicting the outcome of pregnancies of unknown location: Bayesian networks with expert prior information compared to logistic regression. , 2006, Human reproduction.

[30]  Jing Yu,et al.  Computational Inference of Neural Information Flow Networks , 2006, PLoS Comput. Biol..

[31]  Ian Sabroe,et al.  Identifying and hurdling obstacles to translational research , 2007, Nature Reviews Immunology.

[32]  G. Koch,et al.  Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial , 1995 .

[33]  S. Nasraway,et al.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.